{"disease":{"id":"hypo-attenuated-leaflet-thickening","name":"hypo attenuated leaflet thickening"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04552275","title":"The HALT Biomarker Study","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}